Guggulipid raises LDL-cholesterol levels in hypercholesterolaemia

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2003年 / 965卷 / 1期
关键词：
Placebo; Cholesterol; Cholesterol Level; Baseline Level; Herbal Medicine;
D O I：
10.2165/00128415-200309650-00009
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5 / 5
相关论文
共 50 条
  • [1] Coconut oil raises LDL-cholesterol levels
    Lim G.B.
    [J]. Nature Reviews Cardiology, 2020, 17 (4) : 200 - 200
  • [2] Psoriasis LDL-Cholesterol Often raises
    Voos, Dunja
    [J]. AKTUELLE DERMATOLOGIE, 2015, 41 (07) : 269 - 269
  • [3] The effect of adjusting LDL-cholesterol for Lipoprotein(a)-cholesterol on the diagnosis of Familial Hypercholesterolaemia
    Thayabaran, D.
    Tsui, A. P. T.
    Ebmeier, S. J.
    Cegla, J.
    David, A.
    Jones, B.
    [J]. ATHEROSCLEROSIS PLUS, 2022, 49 : S3 - S3
  • [4] The effect of adjusting LDL-cholesterol for Lp(a)-cholesterol on the diagnosis of familial hypercholesterolaemia
    Thayabaran, Darmiga
    Tsui, Anson P. T.
    Ebmeier, Stefan
    Cegla, Jaimini
    David, Alessia
    Jones, Ben
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2023, 17 (02) : 244 - 254
  • [5] Guggulipid and cholesterol levels
    Karuparthy, VR
    Vepachedu, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (21): : 2800 - 2801
  • [6] RELATIONSHIP BETWEEN MEASUREMENTS OF NON-HDL-CHOLESTEROL AND LDL-CHOLESTEROL IN FAMILIAL HYPERCHOLESTEROLAEMIA
    Abreu, J.
    Haralambos, K.
    Ashfield-Watt, P.
    Edwards, R.
    Gingell, R.
    Townsend, D.
    Datta, D.
    McDowell, I. F. W.
    [J]. ATHEROSCLEROSIS, 2016, 245 : E247 - E247
  • [7] Plasma lipoprotein (a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolaemia
    Miltiadous, G.
    Cariolou, M.
    Mitrogianni, Z. O. I.
    Doumas, M.
    Saougkos, V.
    Bairaktari, E.
    Elisaf, M.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 530 - 530
  • [8] Evolocumab reduces LDL-cholesterol levels in FH
    Robson A.
    [J]. Nature Reviews Cardiology, 2020, 17 (11) : 680 - 680
  • [9] INCLISIRAN REDUCES LDL-CHOLESTEROL INDEPENDENT OF GENOTYPE IN SUBJECTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA
    Raal, F. J.
    Kallend, D.
    Ray, K. K.
    Turner, T. A.
    Koenig, W.
    Wright, R. S.
    Wijngaard, P. L.
    Curcio, D.
    Jaros, M. J.
    Leiter, L. A.
    Landmesser, U.
    Kastelein, J. J.
    [J]. ATHEROSCLEROSIS, 2020, 315 : E7 - E8
  • [10] Baseline levels of LDL-cholesterol and lipoprotein(A) and the Ava II polymorphism of the LDL receptor gene influence the response of LDL-cholesterol to pravastatin treatment
    Lahoz, M
    Pena, R
    Mostaza, JM
    Laguna, F
    Garcia-Iglesias, MF
    Taboada, K
    Pinto, X
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 21 - 21
12345